Encompass Health price target raised to $118 from $116 at Barclays
Barclays raised the firm’s price target on Encompass Health (EHC) to $118 from $116 and keeps an Overweight rating on the shares post the Q4 ...
Trust Point Inc. Sells 38 Shares of Elevance Health, Inc. (NYSE:ELV)
Trust Point Inc. decreased its holdings in Elevance Health, Inc. (NYSE:ELV – Free Report) by 4.4% in the fourth quarter, ...
Alphabet's Verily Sells Granular Insurance To Elevance Health Amid Healthcare Strategy Refocus
Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, ...
Elevance Health Inc. stock underperforms Thursday when compared to competitors
Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today
Buying $1000 In ELV: If an investor had bought $1000 of ELV stock 20 years ago, it would be worth $6,446.06 today based on a price of $390.47 for ELV at the time of writing.
Elevance Health to buy insurance business from Alphabet’s Verily, Insider says
Verily, an Alphabet (GOOG) (GOOGL) precision health company, has agreed to sell the company’s Granular insurance business to Elevance Health ...
Verily enters an agreement to sell its insurance business to Elevance Health
Verily CEO Stephen Gillett told staff that the company's Granular insurance business is to be acquired by Elevance Health.